Literature DB >> 20559981

Implantable device therapy for the treatment of resistant hypertension.

Nikhil Joshi1, Jeremy Taylor, John D Bisognano.   

Abstract

The prevalence of resistant hypertension continues to increase and the standard approaches of therapeutic lifestyle changes and drug therapy are ineffective in bringing many of these patients to goal blood pressure. Electrical stimulation of the carotid sinus baroreceptor through a surgically implanted device is presently under clinical investigation and is showing some encouraging early results. This review discusses the evolution of this therapy including a review of the current data available from the early stages of ongoing clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20559981     DOI: 10.1007/s12265-009-9093-x

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  19 in total

1.  Baroceptor function in chronic renal hypertension.

Authors:  J W MCCUBBIN; J H GREEN; I H PAGE
Journal:  Circ Res       Date:  1956-03       Impact factor: 17.367

2.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

3.  An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

Authors:  Karl A Illig; Mark Levy; Luis Sanchez; Gregory D Trachiotis; Charles Shanley; Eric Irwin; Terry Pertile; Robert Kieval; Robert Cody
Journal:  J Vasc Surg       Date:  2006-12       Impact factor: 4.268

4.  Diminished baroreflex sensitivity in high blood pressure.

Authors:  J D Bristow; A J Honour; G W Pickering; P Sleight; H S Smyth
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

5.  Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension.

Authors:  A Neistadt; S I Schwartz
Journal:  Surgery       Date:  1967-06       Impact factor: 3.982

6.  Prevalence of drug resistant hypertension.

Authors:  M H Alderman; N Budner; H Cohen; B Lamport; W L Ooi
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

7.  Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension.

Authors:  T E Lohmeier; J R Lohmeier; A Haque; D A Hildebrandt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

8.  Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats.

Authors:  Ling Xu; Alan F Sved
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-08       Impact factor: 3.619

9.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  2 in total

Review 1.  Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases.

Authors:  Chong Liu; Dingfeng Su
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

2.  Effects of low-level carotid baroreflex stimulation on atrial electrophysiology.

Authors:  Mingyan Dai; Mingwei Bao; Jiafen Liao; Lilei Yu; Yanhong Tang; He Huang; Xi Wang; Congxin Huang
Journal:  J Interv Card Electrophysiol       Date:  2015-04-15       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.